Rethinking screening for breast cancer and prostate cancer
about
sameAs
Screening for breast cancer with mammographyScreening for prostate cancer: systematic review and meta-analysis of randomised controlled trialsT1ρ magnetic resonance: basic physics principles and applications in knee and intervertebral disc imagingFour Principles to Consider Before Advising Women on Screening MammographySIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomasIncreased mammogram-induced DNA damage in mammary epithelial cells aged in vitroMultiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysisRandomised prostate cancer screening trial: 20 year follow-upImplementing a screening program for acromegaly in Latin America: necessity versus feasibilityPopulation-based screening for cancer: hope and hype.Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005-2009.Hypothesis: Towards the origin of cancer epidemics and pathogenesisProstate specific antigen: the past, present and future.Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?Epidemiology of Breast Cancer among Bahraini Women: Data from the Bahrain Cancer Registry.Screening mammography--early detection or over-diagnosis? Contribution from Australian data.Evaluation of an Automated Information Extraction Tool for Imaging Data Elements to Populate a Breast Cancer Screening Registry.Contrast-enhanced ultrasound improved performance of breast imaging reporting and data system evaluation of critical breast lesionsAre treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.Powering cancer screening for overall mortalityTGF-beta biology in mammary development and breast cancer.In-depth proteomic analyses of direct expressed prostatic secretions.Toward a better understanding of patient-reported outcomes in clinical practice.Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy.A novel use of biomarkers in the modeling of cancer activity based on the theory of endobiogeny.Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.Screening for pancreatic cancer: why, how, and who?Imputation of missing values of tumour stage in population-based cancer registrationApolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast CancerPrinciples of cancer screening: lessons from history and study design issues.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain.Cancer screening among patients with advanced cancer.Breast cancer incidence and overdiagnosis in Catalonia (Spain)Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.Evidence-Based Strategies Improve Assessment of Pediatric Bipolar Disorder by Community PractitionersScreening for cancer with molecular markers: progress comes with potential problems.Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.Regression of ductal carcinoma in situ after treatment with acupuncture
P2860
Q24202273-9AFEE3CA-C975-4DF6-89A3-D39B1D238185Q24608493-3764689F-F56C-4BAD-B8F0-255E2897AF6AQ26774896-C72FDCC1-4760-4D2A-AB80-E6E715ADF6CBQ26779927-4FE8602A-8B93-43AD-A8EE-02F39DB94CE9Q28237131-21F55AEA-8A92-42A4-88B8-50922FDFBE68Q28397794-5E022025-E590-427D-A275-3E6512A3FF56Q28657778-AB7D16C5-EA8B-4076-A41C-9AB474DFB4CAQ28741447-98C51F8F-489A-4DB3-A007-FCCCFE8DE82CQ30251471-CA0AAE6E-FA72-4BE8-A111-EC61F6C9DEC5Q30251601-7BA7DC6D-C6E5-4AF5-BAE9-98068C03FA16Q30252065-9E5995C4-CA2D-4F14-A3D2-8686A8FE3D8FQ30317792-73F89CF4-2619-4FE0-83D6-888ACFF6BA84Q30387856-7C798712-3244-40A3-9C64-29826A71F4A2Q30436923-0413ED67-E089-44E3-96B6-0C037C13A1A7Q30768230-23AA5F93-1107-4484-844B-C66164D56B3DQ30813324-98B0B168-00E2-4A7F-9AB0-D435ADB6698EQ30851278-7F4BB67B-C412-4378-AA24-070AB161778AQ30882845-68315ABC-A2BB-449A-B813-25121D074934Q31111425-45569CBE-B689-493D-9A23-2D05806E772AQ33548529-5C688533-9209-43E7-AA8E-A88684F163A1Q33629589-7E0EC1C5-0099-429C-85F5-CA89710FF565Q33681686-060CC0ED-A04E-4F3E-81B1-7BE52A57FEBAQ33849273-20E1C335-2A2E-4261-BA65-184FB0301E7FQ33851795-23A266B5-A887-42BC-925B-43D051ADDEA8Q33913213-1074F188-361D-4E1A-B1B1-7585FE52C1E7Q33924546-D5E9042E-DD35-4805-870E-18B02C127E92Q33938533-1D0DC745-3591-4891-88AA-B0167CCA939BQ33959412-5BBF9F4E-EB52-476A-9558-E4F8F2D0DF20Q34022295-32EB1AC1-2E0A-4BB4-9695-479810FC8DD8Q34037584-2BDA9A9A-EBAE-4B05-9E91-0D18FCC6ED8EQ34065705-6608A84D-2279-4453-A119-AB829E9A2C19Q34108738-37F0265F-5FDC-47D4-8E12-B1CD6842A020Q34137512-729AD836-6EC6-4321-B0EA-D3596905D110Q34143083-10C02EEE-F63B-456F-ABA0-5388AF7B43F6Q34173521-1136FCB0-F2C8-4D36-9BC6-C8A0ADB55002Q34181432-0ABCD6A3-7853-4DA9-AA11-5074E66FEFD6Q34188388-B601C3C6-CB17-4365-ABDD-D7A573B843A4Q34267534-5D0324C2-873B-4D75-A3C2-12B66D22FD04Q34315046-A504F933-D4E6-4ECD-B012-976275805A4DQ34335729-7EB0D635-1106-4C9D-A250-199394C3D4CD
P2860
Rethinking screening for breast cancer and prostate cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Rethinking screening for breast cancer and prostate cancer
@ast
Rethinking screening for breast cancer and prostate cancer
@en
Rethinking screening for breast cancer and prostate cancer
@nl
type
label
Rethinking screening for breast cancer and prostate cancer
@ast
Rethinking screening for breast cancer and prostate cancer
@en
Rethinking screening for breast cancer and prostate cancer
@nl
altLabel
Rethinking Screening for Breast Cancer and Prostate Cancer
@en
prefLabel
Rethinking screening for breast cancer and prostate cancer
@ast
Rethinking screening for breast cancer and prostate cancer
@en
Rethinking screening for breast cancer and prostate cancer
@nl
P3181
P356
P1476
Rethinking screening for breast cancer and prostate cancer
@en
P2093
Ian Thompson
Laura Esserman
P304
P3181
P356
10.1001/JAMA.2009.1498
P407
P50
P577
2009-10-01T00:00:00Z